News from depomed, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:DEPO)

Nov 24, 2015, 08:00 ET

Depomed to Present at Four Investor Events in December

 Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the following investor events during the month of December. Piper...

Nov 19, 2015, 22:05 ET

Depomed Comments on Horizon Withdrawal of Offer to Acquire Company

Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today issued the following statement regarding Horizon Pharma plc's (NASDAQ:...

Nov 17, 2015, 16:25 ET

Depomed Acquires U.S. Rights to Late-Stage, First-in-Class Pain Product from Grunenthal

 Depomed, Inc. (NASDAQ: DEPO) today announced that it has entered into a definitive agreement to acquire the U.S. and Canadian rights to...

Nov 13, 2015, 08:00 ET

Depomed Named to Deloitte's 2015 Technology Fast 500™ List of Fastest Growing Companies in North America

 Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company focused on pain and other central nervous system conditions, announced today...

Nov 11, 2015, 16:00 ET

Depomed to Present at the Stifel Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Stifel 2015 Healthcare Conference in New York City.  The...

Nov 09, 2015, 16:01 ET

Depomed Reports Record Sales in Third Quarter 2015 and Raises Full Year 2015 Guidance

 Depomed, Inc. (Nasdaq: DEPO) today reported financial results and highlighted operational achievements for the quarter ended...

Nov 03, 2015, 17:15 ET

ISS and Glass Lewis Recommend Horizon Pharma Shareholders Vote AGAINST the Issuance of Horizon Shares in Connection with Horizon's Attempted Takeover of Depomed

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today commented on recent reports from Institutional Shareholder Services...

Nov 03, 2015, 16:00 ET

Depomed to Report Third Quarter Fiscal Year 2015 Financial Results on Monday, November 9, 2015

 Depomed, Inc. (NASDAQ: DEPO) today announced that it will release third quarter fiscal year 2015 financial results after the close of market,...

Oct 22, 2015, 08:30 ET

Depomed Comments on Recent Reports Regarding Horizon Pharma's Business Model

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today issued the following statement in response to numerous recent...

Oct 15, 2015, 11:47 ET

Depomed Issues Statement

Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today issued the following statement: We note that Horizon Pharma has recently made...

Sep 28, 2015, 06:31 ET

Depomed Issues Statement on ISS Report

Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today issued the following statement regarding a report by Institutional Shareholder...

Sep 23, 2015, 08:00 ET

Depomed Announces Two Favorable Decisions in Inter Partes Review Proceedings Versus Endo Pharmaceuticals

Depomed, Inc. (Nasdaq: DEPO) today announced favorable decisions by the Patent Trial and Appeal Board (PTAB) of the United States Patent and...

Sep 16, 2015, 08:00 ET

Expert Panel Calls for Best Practices and Practical Diagnostic Tools for Accurate Diagnosis and Management of Complex Pain

Leading health care professionals convened at PAINWeek 2015 in Las Vegas, NV, for an in-depth discussion on the challenges and best practices in...

Sep 15, 2015, 08:00 ET

Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer

Depomed, Inc. (NASDAQ: DEPO) today announced that it has filed a new patent infringement lawsuit in the United States District Court for the...

Sep 14, 2015, 08:00 ET

Depomed's Board of Directors Rejects Horizon Pharma plc's Unsolicited Exchange Offer

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that its Board of Directors, after careful consideration...

Sep 10, 2015, 08:00 ET

Depomed to Present at the Morgan Stanley Global Healthcare Conference

 Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the 2015 Morgan Stanley Global Healthcare Conference in New York...

Sep 09, 2015, 10:00 ET

Depomed and The American Migraine Foundation Join Forces to Highlight Need for the Proper Diagnosis, Management and Treatment of Migraine

 While an estimated 36 million Americans suffer from migraine[2], only one of every three people speak to a doctor[3] about their headaches. Of...

Sep 08, 2015, 09:17 ET

Depomed Issues Statement on Horizon Pharma plc's Unsolicited Exchange Offer

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today confirmed that Horizon Pharma plc (NASDAQ: HZNP) ("Horizon") has...

Sep 02, 2015, 08:00 ET

Depomed's Expanded Portfolio Of Pain Management Products Led By The NUCYNTA® Franchise To Be Highlighted At PAINWeek® 2015

Depomed, Inc. (NASDAQ: DEPO) announced today its participation at PAINWeek® 2015, the nation's largest annual meeting for frontline clinicians...

Aug 19, 2015, 17:35 ET

Depomed's Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma plc

 Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the "Company") today announced that its Board of Directors, after careful consideration...